CAREDX, INC. Cost of Goods Sold (Deprecated 2018-01-31)
CAREDX, INC. (CDNA) reported Cost of Goods Sold (Deprecated 2018-01-31) of $2.27 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-05-10
- CAREDX, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $2.27M, a 2.36% decline year-over-year.
- CAREDX, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.47M, a 35.54% decline year-over-year.
- CAREDX, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.05M, a 38.81% decline year-over-year.
- CAREDX, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $2.18M, a 28.73% decline year-over-year.
- CAREDX, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $9.03M, a 11.86% decline from fiscal 2016.
- CAREDX, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $10.24M.
- CAREDX, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $0.00.
- CAREDX, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $0.00.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $2.27M 10-Q · filed 2018-05-10 | $4.74M derived: sum of 2 quarters · filed 2018-05-10 | $6.79M derived: sum of 3 quarters · filed 2018-05-10 | $8.97M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $4.52M derived: sum of 2 quarters · filed 2018-03-22 | $6.70M derived: sum of 3 quarters · filed 2018-03-22 | $9.03M 10-K · filed 2018-03-22 |
| 2017-09-30 | $2.05M 10-Q · filed 2017-11-09 | $4.23M derived: sum of 2 quarters · filed 2017-11-09 | $6.56M 10-Q · filed 2017-11-09 | $10.39M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | $2.18M 10-Q · filed 2017-08-11 | $4.50M 10-Q · filed 2017-08-11 | $8.33M derived: sum of 3 quarters · filed 2018-05-10 | $11.69M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | $2.33M 10-Q · filed 2018-05-10 | $6.16M derived: sum of 2 quarters · filed 2018-05-10 | $9.51M derived: sum of 3 quarters · filed 2018-05-10 | $12.57M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $7.18M derived: sum of 2 quarters · filed 2018-03-22 | $10.24M derived: sum of 3 quarters · filed 2018-03-22 | $10.24M 10-K · filed 2018-03-22 |
| 2016-09-30 | $3.35M 10-Q · filed 2017-11-09 | $6.41M derived: sum of 2 quarters · filed 2017-11-09 | $6.41M 10-Q · filed 2017-11-09 | $6.41M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-06-30 | $3.06M 10-Q · filed 2017-08-11 | $3.06M 10-Q · filed 2017-08-11 | $3.06M derived: sum of 3 quarters · filed 2018-03-22 | $3.06M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-03-31 | $0.00 10-Q · filed 2017-06-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $0.00 derived: sum of 3 quarters · filed 2018-03-22 | $0.00 derived: sum of 4 quarters · filed 2018-03-22 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $0.00 derived: sum of 3 quarters · filed 2018-03-22 | $0.00 10-K · filed 2018-03-22 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-22 | $0.00 10-Q · filed 2016-08-22 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-04-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |